---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-253519"
form_type: "8-K"
ticker: "IRON"
cik: "0001816736"
company_name: "Disc Medicine, Inc."
filed_at: "2023-10-10T23:59:59+00:00"
generated_at: "2026-06-10T02:42:12.457636+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Disc Medicine enters ATM equity offering agreement for up to $59.7M with Jefferies

## Summary
- Entered Open Market Sale Agreement with Jefferies to sell up to $59.7M of common stock at-the-market.
- Jefferies receives 3% commission on gross proceeds from shares sold as sales agent or principal.
- Company not obligated to sell any shares; offering may be terminated at any time.
- Shares issued under existing S-3 registration statement (No. 333-269272) with prospectus supplement.
- Agreement contains customary representations, warranties, and indemnification provisions.

## SEC filing metadata
- accession: 0001193125-23-253519
- form_type: 8-K
- ticker: IRON
- cik: 0001816736
- company_name: Disc Medicine, Inc.
- filed_at: 2023-10-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816736/000119312523253519/0001193125-23-253519-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816736/000119312523253519/d555586d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-253519
- JSON: https://secwatch.observer/filing/0001193125-23-253519.json
- Plain text: https://secwatch.observer/filing/0001193125-23-253519.txt

## Key facts
- Material Agreements
  Disc Medicine, Inc. entered into Open Market Sale Agreement with Jefferies LLC valued at up to $59.7 million (effective 2023-10-10).
  - Action: entry
  - Agreement: atm program
  - Counterparty: Jefferies LLC
  - Value: up to $59.7 million
  - Effective: 2023-10-10
  source text: On October 10, 2023, Disc Medicine, Inc. (the “Company”) entered into an Open Market Sale Agreement SM (the “Agreement”) with Jefferies LLC (“Jefferies”), pursuant to which the Company may, from time to time in its sole discretion, issue and sell through Jefferies, acting as sales agent, or directly to Jefferies, acting as principal, shares of the Company’s common stock, par value $0.0001 per share (“common stock”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1816736/000119312523253519/0001193125-23-253519-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.